Welcome to the Advanced Platform Technology (APT) Center Homepage

Third generation artifical lung prototype

APT Center News:

CLEVELAND, OH [September 2, 2011] – The Advanced Platform Technology (APT) Center, a Center of Excellence of the U.S. Department of Veterans Affairs (VA), announced today that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to evaluate the feasibility of its peripheral nerve interface for sensory feedback in upper extremity prostheses. This study is an essential step in the development of new techniques to enhance the prosthesis function for individuals with limb loss. The hypothesis-driven research project will determine whether peripheral nerve stimulation with extraneural, multi-channel cuff electrodes provides appropriate sensory feedback to improve performance of a myoelectric prosthesis compared to no sensory feedback. With support from the Department of Veterans Affairs, the APT Center looks forward to enrolling up to 5 participants into its clinical study at the Louis Stokes Cleveland Department of Affairs Medical Center in the United States. Click here to download PDF